| Nitric oxide donors: for pharmaceutical and biological applications PG Wang, TB Cai, N Taniguchi John Wiley & Sons, 2005 | 253 | 2005 |
| Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I inhibitors S Pal, V Kumar, B Kundu, D Bhattacharya, N Preethy, MP Reddy, ... Computational and structural biotechnology journal 17, 291-310, 2019 | 130 | 2019 |
| Cutting edge: Piezo1 mechanosensors optimize human T cell activation CSC Liu, D Raychaudhuri, B Paul, Y Chakrabarty, AR Ghosh, ... The Journal of Immunology 200 (4), 1255-1260, 2018 | 124 | 2018 |
| Recent advances in rare earth-metal triflate catalyzed organic synthesis in green media S Luo, L Zhu, A Talukdar, G Zhang, X Mi, JP Cheng, PG Wang Mini-Reviews in Organic Chemistry 2 (2), 177-202, 2005 | 76 | 2005 |
| Discovery and mechanistic study of tailor-made quinoline derivatives as topoisomerase 1 poison with potent anticancer activity B Kundu, SK Das, S Paul Chowdhuri, S Pal, D Sarkar, A Ghosh, ... Journal of Medicinal Chemistry 62 (7), 3428-3446, 2019 | 54 | 2019 |
| Topoisomerase I inhibitors: Challenges, progress and the road ahead A Talukdar, B Kundu, D Sarkar, S Goon, MA Mondal European Journal of Medicinal Chemistry 236, 114304, 2022 | 39 | 2022 |
| Semisynthetic quercetin derivatives with potent antitumor activity in colon carcinoma A Mukherjee, S Mishra, NK Kotla, K Manna, S Roy, B Kundu, ... Acs Omega 4 (4), 7285-7298, 2019 | 38 | 2019 |
| An oxidation of benzyl methyl ethers with NBS that selectively affords either aromatic aldehydes or aromatic methyl esters AS Mayhoub, A Talukdar, M Cushman The Journal of organic chemistry 75 (10), 3507-3510, 2010 | 35 | 2010 |
| Synthesis and Enzyme Inhibitory Activity of the S-Nucleoside Analogue of the Ribitylaminopyrimidine Substrate of Lumazine Synthase and Product of Riboflavin … A Talukdar, B Illarionov, A Bacher, M Fischer, M Cushman The Journal of organic chemistry 72 (19), 7167-7175, 2007 | 33 | 2007 |
| Regioselective Synthesis of N-β-Hydroxyethylaziridines by the Ring-Opening Reaction of Epoxides with Aziridine Generated in Situ HY Kim, A Talukdar, M Cushman Organic letters 8 (6), 1085-1087, 2006 | 28 | 2006 |
| Discovery and development of a small molecule library with lumazine synthase inhibitory activity A Talukdar, M Breen, A Bacher, B Illarionov, M Fischer, G Georg, QZ Ye, ... The Journal of organic chemistry 74 (15), 5123-5134, 2009 | 27 | 2009 |
| Structural evolution and translational potential for agonists and antagonists of endosomal toll-like receptors A Talukdar, D Ganguly, S Roy, N Das, D Sarkar Journal of Medicinal Chemistry 64 (12), 8010-8041, 2021 | 26 | 2021 |
| Synthesis and Structure− Activity Relationship Study of Isoglobotrihexosylceramide Analogues PGW Wenlan Chen, Chengfeng Xia, Jinhua Wang, Prakash Thapa, Yusen Li ... The Journal of Organic chemistry 72 (26), 9914–9923, 2007 | 26 | 2007 |
| A divergent synthesis of uncommon sugars from furanaldehyde L Zhu, A Talukdar, G Zhang, JP Kedenburg, PG Wang Synlett 2005 (10), 1547-1550, 2005 | 24 | 2005 |
| Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase A Talukdar, E Morgunova, J Duan, W Meining, N Foloppe, L Nilsson, ... Bioorganic & medicinal chemistry 18 (10), 3518-3534, 2010 | 23 | 2010 |
| Kinetic resolution of aryl glycidyl ethers: a practical synthesis of optically pure β-blocker-S-metoprolol MK Gurjar, K Sadalapure, S Adhikari, BV Sarma, A Talukdar, ... Heterocycles 7 (48), 1471-1476, 1998 | 23 | 1998 |
| A chemical switch for transforming a purine agonist for toll-like receptor 7 to a clinically relevant antagonist A Mukherjee, D Raychaudhuri, BP Sinha, B Kundu, M Mitra, B Paul, ... Journal of Medicinal Chemistry 63 (9), 4776-4789, 2020 | 21 | 2020 |
| Understanding the riboflavin biosynthesis pathway for the development of antimicrobial agents B Kundu, D Sarkar, N Ray, A Talukdar Medicinal research reviews 39 (4), 1338-1371, 2019 | 18 | 2019 |
| Systematic optimization of potent and orally bioavailable purine scaffold as a dual inhibitor of toll-like receptors 7 and 9 B Kundu, D Raychaudhuri, A Mukherjee, BP Sinha, D Sarkar, ... Journal of Medicinal Chemistry 64 (13), 9279-9301, 2021 | 16 | 2021 |
| Activity-guided development of potent and selective toll-like receptor 9 antagonists B Paul, O Rahaman, S Roy, S Pal, S Satish, A Mukherjee, AR Ghosh, ... European Journal of Medicinal Chemistry 159, 187-205, 2018 | 16 | 2018 |
